Wellcome Leap Inc. – Interim award (360G-Wellcome-220960_Z_20_Z)

£782,901

In early February 2020 Wellcome’s BoG approved the appointment of Regina Dugan as CEO of the Wellcome Leap Fund (WLF), the relocation of the WLF’s primary place of business to the U.S. and the creation of a U.S. not-for-profit entity within the Wellcome group (Leap US). This grant is a mobilisation fund to support the initial activities required for Leap US’ set up and strategy development, prior to the awarding of full grant which will be administered upon BoG approving the CEO’s strategy and business plan for the WLF.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 782901
Applicant Surname Dugan
Approval Committee Internal Decision Panel
Award Date 2020-09-30T00:00:00+00:00
Financial Year 2019/20
Grant Programme: Title Wellcome Leap Inc.
Internal ID 220960/Z/20/Z
Lead Applicant Dr Regina Dugan
Partnership Value 782901
Planned Dates: End Date 2021-03-30T00:00:00+00:00
Planned Dates: Start Date 2020-03-30T00:00:00+00:00
Recipient Org: Country United States
Region International